KIAA1024L_A730017C20Rik inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the KIAA1024L gene, also referred to in some contexts as A730017C20Rik in mouse models. This gene encodes a protein of interest due to its involvement in various cellular processes, including intracellular signaling pathways, gene expression regulation, and possibly autophagy-related mechanisms. Inhibitors targeting this gene are chemically tailored to interact with the protein products of KIAA1024L, disrupting their normal function and allowing for detailed study of the biological consequences of such inhibition. Structurally, these inhibitors may possess distinct active moieties that enable specific binding to the target protein, allowing them to block its normal activity with high specificity.
The study of KIAA1024L_A730017C20Rik inhibitors is important in the exploration of cellular regulatory mechanisms and how these proteins influence the cell's metabolic and signaling networks. By inhibiting this gene's function, researchers can gain insights into its role in normal cellular homeostasis and its involvement in any dysregulated pathways, providing valuable information about the broader molecular environment. The chemical structure and functional groups of these inhibitors may vary, but they generally include scaffolds that promote strong interactions with the target, often through hydrogen bonds, hydrophobic contacts, or electrostatic interactions. This specificity allows researchers to finely tune experiments aimed at elucidating the fundamental biological roles of KIAA1024L and its orthologs across different species.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT inhibits gamma-secretase, an enzyme required for the proteolytic cleavage of membrane integral NOTCH2 associated receptor 2 (NOTCH2), preventing its activation by precluding the release of the intracellular domain that acts as a transcriptional activator. | ||||||
L-685,458 | 292632-98-5 | sc-204042 sc-204042A | 1 mg 5 mg | $337.00 $1000.00 | 4 | |
L-685,458 is a specific gamma-secretase inhibitor that prevents the cleavage and subsequent activation of NOTCH2 by inhibiting the enzyme complex responsible for its activation. | ||||||
MK-0752 | 471905-41-6 | sc-364534 sc-364534A | 10 mg 50 mg | $592.00 $1550.00 | ||
MK-0752 serves as a gamma-secretase inhibitor, thereby inhibiting the proteolytic activation of NOTCH2, which is necessary for the receptor's signaling function. | ||||||
RO-4929097 | 847925-91-1 | sc-364602 sc-364602A | 10 mg 50 mg | $439.00 $1417.00 | 1 | |
RO4929097 functions as a gamma-secretase inhibitor, which impairs the proteolytic cleavage of NOTCH2, essential for its subsequent activation and cellular signaling roles. | ||||||
Dibenzazepine (Deshydroxy LY 411575) | 209984-56-5 | sc-207554 sc-207554A | 2 mg 5 mg | $235.00 $260.00 | 4 | |
LY-411575 acts as a potent gamma-secretase inhibitor, which disrupts the cleavage and thus the activation of NOTCH2, directly inhibiting its signaling capabilities. | ||||||
Semagacestat | 425386-60-3 | sc-364614 sc-364614A | 10 mg 50 mg | $350.00 $1200.00 | 1 | |
Semagacestat inhibits gamma-secretase, leading to a reduction in NOTCH2 activation by preventing the necessary cleavage events for its signaling function. | ||||||
BMS-708163 | 1146699-66-2 | sc-364444 sc-364444A | 10 mg 50 mg | $480.00 $1455.00 | 1 | |
BMS-708163 selectively inhibits gamma-secretase, which is responsible for the activation of NOTCH2 through proteolytic processing, thereby inhibiting NOTCH2 signaling. | ||||||
PF-3084014 | 1290543-63-3 | sc-507501 | 5 mg | $130.00 | ||
Nirogacestat is a gamma-secretase inhibitor that blocks the enzyme complex necessary for NOTCH2 activation through cleavage, directly inhibiting its signaling function. | ||||||